Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KOD Kodiak Sciences Inc.

Trading 10-22 10:20:42 EDT

87.75

+0.03

+0.03%

High89.52	Low86.09	Vol123.20K
Open87.14	D1 Closing87.72	Amplitude3.91%
Mkt Cap5.49B	Tradable Cap3.25B	Total Shares62.58M
T/O10.77M	T/O Rate0.33%	Tradable Shares36.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":87.75,"timestamp":1792678840682,"preClose":87.72,"halted":0,"volume":123195,"delay":0,"changeRate":0.0003419972640219008,"floatShares":36991100,"shares":62578441,"eps":-4.157111,"marketStatus":"Trading","change":0.03,"latestTime":"10-22 10:20:42 EDT","open":87.14,"high":89.5199,"low":86.09,"amount":10774091.410050001,"amplitude":0.039101,"askPrice":87.78,"askSize":72,"bidPrice":87.36,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-4.157111,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":87.72,"preHourTrading":{"tag":"盘前","latestPrice":87.02,"preClose":87.72,"latestTime":"09:28 EDT","volume":6802,"amount":597050.8555599999,"timestamp":1792675725016,"change":-0.7,"changeRate":-0.00798,"amplitude":0.150807},"postHourTrading":{"tag":"盘后","latestPrice":87.8,"preClose":87.72,"latestTime":"19:55 EDT","volume":12693,"amount":1113935.8478,"timestamp":1792626947130,"change":0.08,"changeRate":0.000912,"amplitude":0.006042},"volumeRatio":0.875781,"impliedVol":0.8745,"impliedVolPercentile":0.2271},"requestUrl":"/m/hq/s/KOD/wiki","defaultTab":"wiki","newsList":[{"id":"1158029511","title":"Movement Alert｜Kodiak Sciences Inc. Intraday Decline 5.01%, Prior Phase 3 eye-data progress and director buying remain in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1158029511","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158029511?lang=en_us&edition=fundamental","pubTime":"2026-10-22 02:51","pubTimestamp":1792608705,"startTime":"0","endTime":"0","summary":"On October 22, Kodiak Sciences Inc. fell 5.01% in Regular Trading, trading at $88.04 per share, with turnover of $55.33 million.The main public catalyst still being discussed is the company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Sciences Drops as Phase 3 AMD Progress and Director Buying Loom","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677789611","title":"Kodiak Sciences Inc.: May Offer up to $350 Mln Common Stock Under Distribution Agreement with J.p. Morgan - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2677789611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677789611?lang=en_us&edition=fundamental","pubTime":"2026-10-21 05:19","pubTimestamp":1792531196,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nFWN4661SU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677293611","title":"Kodiak Sciences Inc.: Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2677293611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677293611?lang=en_us&edition=fundamental","pubTime":"2026-10-21 05:19","pubTimestamp":1792531196,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nFWN4661SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196767805","title":"Movement Alert｜Kodiak Sciences Inc. Intraday Rise 5.11% in Regular Trading, Phase 3 eye-drug progress and large insider buying remain in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1196767805","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196767805?lang=en_us&edition=fundamental","pubTime":"2026-10-20 23:31","pubTimestamp":1792510268,"startTime":"0","endTime":"0","summary":"On October 20, Kodiak Sciences Inc. rose 5.11% in Regular Trading, trading at $96.02 per share, with turnover of $27.49 million.The move aligns with continuing market focus on two established...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Sciences Rises on $157M Baker Bros. Insider Buy","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164527464","title":"Movement Alert｜Kodiak Sciences Inc. Overnight Rise 5.07%, Phase 3 eye-drug progress and major director share purchase remain in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1164527464","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164527464?lang=en_us&edition=fundamental","pubTime":"2026-10-20 14:17","pubTimestamp":1792477054,"startTime":"0","endTime":"0","summary":"On October 20, Kodiak Sciences Inc. rose 5.07% Overnight, trading at $95.98 per share, with turnover of $2124.73.The clearest public catalyst remained the continued market reaction to two positive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Sciences Climbs on Phase 3 Eye-Drug Progress and Director Baker's $157M Buy","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184143562","title":"Movement Alert｜Kodiak Sciences Inc. Intraday Rise 6.27% in Regular Trading, Phase 3 eye-drug progress and major insider buying remain in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1184143562","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184143562?lang=en_us&edition=fundamental","pubTime":"2026-10-20 00:13","pubTimestamp":1792426421,"startTime":"0","endTime":"0","summary":"On October 20, Kodiak Sciences Inc. rose 6.27% in Regular Trading, trading at $91.135/share, with turnover of $23.2711 million.The main public catalyst in focus remains the company’s late-September...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Rises as Zenkuda Phase 3 Win and $157M Baker Buy Fuel Rally","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675550439","title":"Kodiak Sciences (KOD), What Is Behind The Latest Move?","url":"https://stock-news.laohu8.com/highlight/detail?id=2675550439","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675550439?lang=en_us&edition=fundamental","pubTime":"2026-10-16 10:29","pubTimestamp":1792117788,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) has moved into focus after unveiling first time scientific results from its pivotal DAYBREAK Phase 3 trial and other late stage programs at the American Academy of Ophthalmology 2026 meeting.\nThe recent American Academy of Ophthalmology presentations arrived after a sharp re-rating in Kodiak Sciences, with a 30-day share price return of 167.11% and a year-to-date share price return of 238.66%. That move sits alongside a very large 3-year total shareholder return, while...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-what-is-behind-the-latest-move","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-what-is-behind-the-latest-move","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","BK4139","KOD","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167262473","title":"Movement Alert｜Kodiak Sciences Inc. Intraday Rise 5.2% in Regular Trading, Phase 3 eye-drug progress and large insider buying remain in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1167262473","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167262473?lang=en_us&edition=fundamental","pubTime":"2026-10-16 00:32","pubTimestamp":1792081969,"startTime":"0","endTime":"0","summary":"On October 16, Kodiak Sciences Inc. rose 5.2% in Regular Trading, trading at $85.31 per share, with turnover of $46.3375 million.The move aligns with continued market digestion of two previously...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Kodiak Sciences Rises on $157M Insider Buy and Phase 3 Win","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675329162","title":"Kodiak Sciences put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2675329162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675329162?lang=en_us&edition=fundamental","pubTime":"2026-10-15 01:35","pubTimestamp":1791999314,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Kodiak Sciences (KOD) with 5,384 puts trading, or 1.7x expected. Most active are Oct-26 50 puts and Oct-26 80 puts, with tota...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kodiak-sciences-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kodiak-sciences-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KOD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136019147","title":"Movement Alert｜Kodiak Sciences Inc. Falls 5.6% in Regular Trading, Earlier Insider Buying Tailwind Loses Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1136019147","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136019147?lang=en_us&edition=fundamental","pubTime":"2026-10-14 22:23","pubTimestamp":1791987832,"startTime":"0","endTime":"0","summary":"On October 14, Kodiak Sciences Inc. fell 5.6% in Regular Trading, trading at $86.2128 per share, with turnover of $28.4683 million.The most relevant recent catalyst is a fading follow-through from...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kodiak Falls as Baker Bros Insider Buying Boost Fades","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675631405","title":"Canaccord Genuity Reaffirms Their Buy Rating on Kodal Minerals (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675631405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675631405?lang=en_us&edition=fundamental","pubTime":"2026-10-14 16:35","pubTimestamp":1791966922,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Will Dalby from Canaccord Genuity reiterated a Buy rating on Kodal Minerals, with a price target of p0.70. Accordin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-kodal-minerals-kod-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-kodal-minerals-kod-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KOD","MTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133290252","title":"Movement Alert｜Kodiak Sciences Inc. Falls 5.03% in Regular Trading, Insider Buying Boost Shows Signs of Fading","url":"https://stock-news.laohu8.com/highlight/detail?id=1133290252","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133290252?lang=en_us&edition=fundamental","pubTime":"2026-10-14 01:48","pubTimestamp":1791913691,"startTime":"0","endTime":"0","summary":"On October 14, Kodiak Sciences Inc. fell 5.03% in Regular Trading, trading at $94.34 per share, with turnover of $68.96 million.The most relevant recent catalyst in public information is a large...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kodiak Sciences Drops as Baker Bros. Insider Boost Fades","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674253872","title":"Kodiak Sciences Price Target Raised to $126.00/Share from $96.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2674253872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674253872?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:46","pubTimestamp":1791805560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KOD/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674587193","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Kodiak Sciences (KOD), Newron Pharmaceuticals SpA (OtherNWPHF) and Illumina (ILMN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674587193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674587193?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:40","pubTimestamp":1791801613,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kodiak Sciences (KOD), Newron Pharmaceuticals SpA (NWPHF) and Ill...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-kodiak-sciences-kod-newron-pharmaceuticals-spa-othernwphf-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-kodiak-sciences-kod-newron-pharmaceuticals-spa-othernwphf-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4585","LU0029874061.USD","BK4534","BK4007","BK4505","BK4581","BK4588","GNOM","XBI","LABU","KOD","ILMN","LU0128526141.USD","HCSG","XLV","GNMX","BK4139","BK4137","BK4548","NWPHF","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188939416","title":"Movement Alert｜Kodiak Sciences Inc. Rises 5.63% in Regular Trading, Insider Buying Reinforces Market Confidence After Phase 3 Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1188939416","media":"Market Focus","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188939416?lang=en_us&edition=fundamental","pubTime":"2026-10-09 23:57","pubTimestamp":1791561445,"startTime":"0","endTime":"0","summary":"On October 9, Kodiak Sciences Inc. rose 5.63% in regular trading, trading at $99.64 per share with Turnover of $46.97 million. The movement comes as non-executive director Felix Baker purchased $157...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Insider $157M Buy After Phase 3 Win Lifts Kodiak Sciences","news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673855097","title":"Kodiak Sciences to Present Phase 3 Daybreak Wet AMD Data for Zenkuda at AAO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673855097","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673855097?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:01","pubTimestamp":1791370911,"startTime":"0","endTime":"0","summary":"Kodiak Sciences to present Phase 3 DAYBREAK wet AMD data for Zenkuda at AAO 2026Kodiak Sciences flagged upcoming AAO 2026 presentations covering three late-stage retina programs, led by first scientif","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL53Z388:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051045","title":"Kodiak Sciences Stock Pick of the Week at Smart Insider Following Insider Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051045","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051045?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:40","pubTimestamp":1791294002,"startTime":"0","endTime":"0","summary":"Kodiak Sciences  was Smart Insider's stock pick of the week after non-executive director Felix Baker bought $157 million in shares on Sept. 29.Baker, who has served on the board since September 2015, acquired the shares at $80.85 apiece, increasing his stake by 10%, Smart Insider said in a Tuesday note.The purchase was made indirectly through Baker Bros. Advisors, where Baker is a managing member, with the investment firm now holding 35% of Kodiak Sciences, according to the note.Smart Insider said Baker's history with the stock has been \"poor\", but described the latest purchase as \"notable\" because it was his largest to date and was made at a higher price than his previous transaction - a $60 million subscription at $23 in December 2025.Smart Insider ranked Kodiak Sciences +1, indicating a strong positive signal.Price: 92.90, Change: -0.91, Percent Change: -0.97","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KOD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136012342","title":"Movement Alert｜Kodiak Sciences Inc. Intraday Decline 5.09%, Profit-Taking Pressure Emerges After Key Data Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1136012342","media":"Market Focus","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136012342?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:21","pubTimestamp":1791210080,"startTime":"0","endTime":"0","summary":"October 5, Kodiak Sciences Inc. fell 5.09% during regular trading, trading at $89.65 per share. The decline reflects profit-taking pressure after disclosure of benchmark ophthalmology data.This...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Sciences Slides on Profit-Taking After Key Data Release","news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673508808","title":"Analysts Are Bullish on Top Healthcare Stocks: Liquidia Technologies (LQDA), Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673508808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673508808?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:00","pubTimestamp":1791208824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), Kodiak Sciences (KOD) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-liquidia-technologies-lqda-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-liquidia-technologies-lqda-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","BK4139","KOD","LU0029874061.USD","BK4007","BK4585","HCSG","BK4505","LABU","LQDA","XBI","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121105661","title":"Movement Alert｜Kodiak Sciences Inc. Declines 5.08% in Regular Trading, Trading at $93.76","url":"https://stock-news.laohu8.com/highlight/detail?id=1121105661","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121105661?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:01","pubTimestamp":1790949717,"startTime":"0","endTime":"0","summary":"On October 2, Kodiak Sciences Inc. fell 5.08% in regular trading, trading at $93.76 USD/share, with Turnover of $31.66 million.Within the Biotechnology sector where Kodiak Sciences Inc. belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com;ir.kodiak.com","stockEarnings":[{"period":"1week","weight":0.0818},{"period":"1month","weight":1.7057},{"period":"3month","weight":1.1385},{"period":"6month","weight":0.9563},{"period":"1year","weight":3.6168},{"period":"ytd","weight":2.1373}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.076525},{"month":2,"riseRate":0.5,"avgChangeRate":-0.093763},{"month":3,"riseRate":0.125,"avgChangeRate":-0.076889},{"month":4,"riseRate":0.625,"avgChangeRate":0.017136},{"month":5,"riseRate":0.5,"avgChangeRate":0.047406},{"month":6,"riseRate":0.75,"avgChangeRate":0.031274},{"month":7,"riseRate":0.625,"avgChangeRate":0.076709},{"month":8,"riseRate":0.5,"avgChangeRate":0.003695},{"month":9,"riseRate":0.75,"avgChangeRate":0.304064},{"month":10,"riseRate":0.625,"avgChangeRate":0.176937},{"month":11,"riseRate":0.75,"avgChangeRate":0.296496},{"month":12,"riseRate":0.625,"avgChangeRate":0.266402}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kodiak Sciences Inc.(KOD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kodiak Sciences Inc.(KOD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction